BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bus P, Chua JS, Klessens CQF, Zandbergen M, Wolterbeek R, van Kooten C, Trouw LA, Bruijn JA, Baelde HJ. Complement Activation in Patients With Diabetic Nephropathy. Kidney Int Rep 2018;3:302-13. [PMID: 29725633 DOI: 10.1016/j.ekir.2017.10.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Wendt R, Siwy J, He T, Latosinska A, Wiech T, Zipfel PF, Tserga A, Vlahou A, Rupprecht H, Catanese L, Mischak H, Beige J. Molecular Mapping of Urinary Complement Peptides in Kidney Diseases. Proteomes 2021;9:49. [DOI: 10.3390/proteomes9040049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Tan SM, Snelson M, Østergaard JA, Coughlan MT. The complement pathway: New insights into immunometabolic signalling in diabetic kidney disease. Antioxid Redox Signal 2021. [PMID: 34806406 DOI: 10.1089/ars.2021.0125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shen F, Liu M, Pei F, Yu L, Yang X. Role of uromodulin and complement activation in the progression of kidney disease. Oncol Lett 2021;22:829. [PMID: 34691256 DOI: 10.3892/ol.2021.13090] [Reference Citation Analysis]
4 Wendt R, Siwy J, He T, Latosinska A, Wiech T, Zipfel PF, Tserga A, Vlahou A, Catanese L, Rupprecht H, Mischak H, Beige J. Molecular mapping of urinary complement peptides in kidney diseases.. [DOI: 10.1101/2021.06.24.21259458] [Reference Citation Analysis]
5 King BC, Blom AM. Complement in metabolic disease: metaflammation and a two-edged sword. Semin Immunopathol 2021. [PMID: 34159399 DOI: 10.1007/s00281-021-00873-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
6 Wan S, Wan S, Jiao X, Cao H, Gu Y, Yan L, Zheng Y, Niu P, Shao F. Advances in understanding the innate immune-associated diabetic kidney disease. FASEB J 2021;35:e21367. [PMID: 33508160 DOI: 10.1096/fj.202002334R] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Angeletti A, Cantarelli C, Petrosyan A, Andrighetto S, Budge K, D'Agati VD, Hartzell S, Malvi D, Donadei C, Thurman JM, Galešić-Ljubanović D, He JC, Xiao W, Campbell KN, Wong J, Fischman C, Manrique J, Zaza G, Fiaccadori E, La Manna G, Fribourg M, Leventhal J, Da Sacco S, Perin L, Heeger PS, Cravedi P. Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis. J Exp Med 2020;217:e20191699. [PMID: 32717081 DOI: 10.1084/jem.20191699] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 21.0] [Reference Citation Analysis]
8 van Aanhold CCL, Dijkstra KL, Bos M, Wolterbeek R, van den Berg BM, Bruijn JA, Bajema IM, Baelde HJ. Reduced Glomerular Endothelial Thrombomodulin Is Associated with Glomerular Macrophage Infiltration in Diabetic Nephropathy. Am J Pathol 2021;191:829-37. [PMID: 33617784 DOI: 10.1016/j.ajpath.2021.02.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Koopman JJE, van Essen MF, Rennke HG, de Vries APJ, van Kooten C. Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys. Front Immunol 2020;11:599974. [PMID: 33643288 DOI: 10.3389/fimmu.2020.599974] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
10 董 琳. Research Progress of Complement System in Microangiopathy of Type 2 Diabetes Mellitus. ACM 2021;11:5190-5195. [DOI: 10.12677/acm.2021.1111766] [Reference Citation Analysis]
11 Hoevenaar M, Goossens D, Roorda J. Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads. J Renin Angiotensin Aldosterone Syst 2020;21:1470320320979097. [PMID: 33283602 DOI: 10.1177/1470320320979097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Duan S, Sun L, Nie G, Chen J, Zhang C, Zhu H, Huang Z, Qian J, Zhao X, Xing C, Zhang B, Yuan Y. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes. Front Immunol 2020;11:2073. [PMID: 32983156 DOI: 10.3389/fimmu.2020.02073] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
13 Daryabor G, Atashzar MR, Kabelitz D, Meri S, Kalantar K. The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System. Front Immunol 2020;11:1582. [PMID: 32793223 DOI: 10.3389/fimmu.2020.01582] [Cited by in Crossref: 89] [Cited by in F6Publishing: 99] [Article Influence: 44.5] [Reference Citation Analysis]
14 Zheng XP, Nie Q, Feng J, Fan XY, Jin YL, Chen G, Du JW. Kidney-targeted baicalin-lysozyme conjugate ameliorates renal fibrosis in rats with diabetic nephropathy induced by streptozotocin. BMC Nephrol 2020;21:174. [PMID: 32398108 DOI: 10.1186/s12882-020-01833-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
15 Gaya da Costa M, Poppelaars F, Berger SP, Daha MR, Seelen MA. The lectin pathway in renal disease: old concept and new insights. Nephrol Dial Transplant 2018;33:2073-9. [PMID: 29701808 DOI: 10.1093/ndt/gfy073] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
16 Ajjan RA, Schroeder V. Role of complement in diabetes. Mol Immunol 2019;114:270-7. [PMID: 31400630 DOI: 10.1016/j.molimm.2019.07.031] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
17 Huang Y, Xu J, Wu X, Chen X, Bai X, Zhuang Y, Fang J, Lin X. High Expression of Complement Components in the Kidneys of Type 2 Diabetic Rats With Diabetic Nephropathy. Front Endocrinol (Lausanne). 2019;10:459. [PMID: 31338070 DOI: 10.3389/fendo.2019.00459] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
18 Lindner TH. Diabetes und Niere – nach vielen Jahren der Stagnation endlich Neuigkeiten? Diabetologe 2019;15:416-425. [DOI: 10.1007/s11428-019-0497-1] [Reference Citation Analysis]
19 van de Lest NA, Zandbergen M, Wolterbeek R, Kreutz R, Trouw LA, Dorresteijn EM, Bruijn JA, Bajema IM, Scharpfenecker M, Chua JS. Glomerular C4d deposition can precede the development of focal segmental glomerulosclerosis. Kidney Int 2019;96:738-49. [PMID: 31327475 DOI: 10.1016/j.kint.2019.04.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
20 Pelletier K, Bonnefoy A, Chapdelaine H, Pichette V, Lejars M, Madore F, Brachemi S, Troyanov S. Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy. Kidney Int Rep 2019;4:797-805. [PMID: 31194090 DOI: 10.1016/j.ekir.2019.03.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
21 Okrój M, Potempa J. Complement Activation as a Helping Hand for Inflammophilic Pathogens and Cancer. Front Immunol 2018;9:3125. [PMID: 30687327 DOI: 10.3389/fimmu.2018.03125] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
22 Sun ZJ, Li XQ, Chang DY, Wang SX, Liu G, Chen M, Zhao MH. Complement deposition on renal histopathology of patients with diabetic nephropathy. Diabetes Metab 2019;45:363-8. [PMID: 30243617 DOI: 10.1016/j.diabet.2018.08.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]